Overview
EyeD Pharma is dedicated to improving the life of patients suffering from ophthalmic diseases with innovative sustained release micro-implants and complex therapeutics. The company focuses on treating glaucoma, dry eye disease, and chronic or post-surgery inflammation at the back of the eye, aiming to develop therapeutic alternatives that could ensure 100% patient compliance and reduce treatment side effects.
Key people
In the news
- UniD Manufacturing, "le petit frère" d'EyeD Pharma, racheté par Besins Healthcare12:28 Lié depuis sa création à EyeD Pharma, le sous-traitant UniD Manufacturing change de main. Il est repris par le groupe Besins Healthcare. UniD se charge notamment de la production de l'implant oculaire...
L'Echo Entreprises · 7 Jul 2026
- We're hiring! At EyeD Pharma, we're looking for an R&D QA Manager to join our team in Belgium. This is an exciting opportunity to play a key role in the development of innovative ophthalmic therapies, working at the intersection of quality, R&D and pharmaceutical innovation within a fast-growing clinical-stage biotech. If you're passionate about quality, enjoy working in a collaborative environment and want to contribute to therapies that could improve the lives of millions of patients, we'd love to hear from you. Discover the
- EN] We are proud to see our work featured in the health supplement of La Libre, to be published tomorrow. The article highlights the development of our innovative micro-implant for glaucoma treatment, a technology designed to provide sustained drug delivery and reduce reliance on daily eye drops. This breakthrough could contribute to improved treatment adherence and quality of life for patients. This recognition is, above all, a testament to the work, expertise, and commitment of our teams and partners, who strive every day to
Alumni 1 went on to found or lead
- PSofie BaetenBoard Member→CEO and co-founder Qbic III at Qbic Fund | Venture Capital
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.